Precigen (PGEN) EBT Margin Growth (3y) (2015 - 2025)
Precigen (PGEN) EBT Margin Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45,120.00 |
| Sep 30, 2025 | -1.55 Mn |
| Jun 30, 2025 | -251,264.00 |
| Mar 31, 2025 | -360,372.00 |
| Dec 31, 2024 | -80,178.00 |
| Sep 30, 2024 | -239.58 Mn |
| Jun 30, 2024 | -762,273.00 |
| Mar 31, 2024 | -214,231.00 |
| Dec 31, 2023 | -251,043.00 |
| Sep 30, 2023 | -198.00 Mn |
| Jun 30, 2023 | -110,157.00 |
| Dec 31, 2022 | 36,991.00 |
| Sep 30, 2022 | 21,547.00 |
| Jun 30, 2022 | -79,984.00 |
| Mar 31, 2022 | -20,025.00 |
| Dec 31, 2021 | 75,858.00 |
| Sep 30, 2021 | -54,836.00 |
| Jun 30, 2021 | -65,367.00 |
| Mar 31, 2021 | 4,925.00 |
| Dec 31, 2020 | -23,011.00 |